TRODELVY (sacituzumab govitecan-hziy) In Pretreated mTNBC nad HR+/HER2-mBC: Clinical Considerations

When:  Jun 22, 2023 from 18:00 to 20:00 (ET)
Associated with  National Capital

Please join us for an educational program
TRODELVY (sacituzumab govitecan-hziy) In Pretreated mTNBC nad HR+/HER2-mBC: Clinical Considerations and Patient Counseling 

Presented by:
Heidi Haynes, OCN, CRNP, MD
Senior Oncology Nurse Educator
Gilead Oncology

Location:
The Capital Grille
5310 western Avenue
Chevy Chase, MD 20815

RSVP or email by June 19, 2023 to
colleen.hagan@gilead.com OR (703) 862-9518

Time: 6:00pm. Please come 30 minute early for registration

Contact

Colleen Hagan
703-862-9518
colleen.hagan@gilead.com